"The U.S. Food and Drug Administration today approved Lymphoseek (technetium Tc 99m tilmanocept) Injection, a radioactive diagnostic imaging agent that helps doctors locate lymph nodes in patients with breast cancer or melanoma who are undergoing "...
(Generic versions may still be available.)
Mithracin Patient Information including How Should I Take
In this Article
- What is plicamycin (Mithracin)?
- What are the possible side effects of plicamycin (Mithracin)?
- What is the most important information I should know about plicamycin (Mithracin)?
- Who should not take plicamycin (Mithracin)?
- How should I take plicamycin (Mithracin)?
- What happens if I miss a dose (Mithracin)?
- What happens if I overdose (Mithracin)?
- What should I avoid while taking plicamycin (Mithracin)?
- What other drugs will affect plicamycin (Mithracin)?
- Where can I get more information?
Who should not take plicamycin (Mithracin)?
Before taking plicamycin, tell your doctor if you have
- liver disease;
- kidney disease;
- bone marrow problems; or
- a bleeding disorder.
You may not be able to take plicamycin, or you may require a dosage adjustment or special monitoring during treatment if you have any of the conditions listed above.
Plicamycin is in the FDA pregnancy category X. This means that plicamycin is known to cause birth defects in an unborn baby. Plicamycin may also affect egg production in women and sperm production in men. Do not take plicamycin if you are pregnant or could become pregnant during treatment. Contraceptive measures are recommended during treatment with plicamycin.
It is not known whether plicamycin passes into breast milk. Do not take plicamycin without first talking to your doctor if you are breast feeding a baby.
How should I take plicamycin (Mithracin)?
Plicamycin should only be administered under the supervision of a qualified healthcare provider experienced in the use of cancer chemotherapeutic agents.
Your doctor will determine the correct amount and frequency of treatment with plicamycin depending upon the type of cancer being treated and other factors. Talk to your doctor if you have any questions or concerns regarding the treatment schedule.
Your doctor will probably want you to have regularly scheduled blood tests and other medical evaluations during treatment with plicamycin to monitor progress and side effects.
Your healthcare provider will store cladribine as directed by the manufacturer. If you are storing cladribine, follow the directions provided by your healthcare provider.
Additional Mithracin Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.